This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Mesoblast, Inc. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Innovations by Claude Bernard in Treating Multiple Sclerosis
Introduction
Claude Bernard is a notable inventor based in Clayton, Australia. He has made significant contributions to the field of medical science, particularly in the treatment of neurological diseases. His innovative approach focuses on utilizing specific cell types to address complex health issues.
Latest Patents
Bernard holds a patent for "Methods of treating multiple sclerosis using STRO-1+ and TNAP+ multipotential cells." This patent outlines a method for treating inflammatory neurological diseases by administering a population of cells enriched for STRO-1 cells and/or their progeny, along with soluble factors derived from these cells. This groundbreaking work has the potential to change the landscape of treatment for multiple sclerosis.
Career Highlights
Claude Bernard is associated with Mesoblast, Inc., a company known for its pioneering work in regenerative medicine. His role at the company has allowed him to further his research and develop innovative treatments that could benefit many patients suffering from neurological disorders.
Conclusion
Claude Bernard's contributions to the field of medicine, particularly through his patent on treating multiple sclerosis, highlight the importance of innovation in healthcare. His work exemplifies how targeted therapies can lead to significant advancements in treating complex diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile